Art
J-GLOBAL ID:201402268132538020   Reference number:14A1146429

Quinine Compared to 4β-Hydroxycholesterol and Midazolam as Markers for CYP3A Induction by Rifampicin

リファンピシンによるCYP3A誘導のマーカーとしての4β-ヒドロキシコレステロールおよびミダゾラムと比較したキニン
Author (10):
Material:
Volume: 29  Issue:Page: 352-355 (J-STAGE)  Publication year: 2014 
JST Material Number: X0758A  ISSN: 1347-4367  Document type: Article
Article type: 短報  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1146429&from=J-GLOBAL&jstjournalNo=X0758A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical biopharmacy  ,  Interactions of drugs 
Substance index (8):
Substance index
Chemical Substance indexed to the Article.
Reference (16):
  • 1) Backman, J. T., Olkkola, K. T., Ojala, M., Laaksovirta, H. and Neuvonen, P. J.: Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. Epilepsia, 37: 253-257 (1996).
  • 2) Gerber, J. G., Rosenkranz, S. L., Fichtenbaum, C. J., Vega, J. M., Yang, A., Alston, B. L., Brobst, S. W., Segal, Y. and Aberg, J. A.: Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. J. Acquir. Immune Defic. Syndr., 39: 307-312 (2005).
  • 3) Pal, D. and Mitra, A. K.: MDR- and CYP3A4-mediated drug-drug interactions. J. Neuroimmune Pharmacol., 1: 323-339 (2006).
  • 4) Björkhem-Bergman, L., Bäckström, T., Nylén, H., Rönquist-Nii, Y., Bredberg, E., Andersson, T. B., Bertilsson, L. and Diczfalusy, U.: Comparison of endogenous 4β-hydroxycholesterol with midazolam as markers for CYP3A4 induction by rifampicin. Drug Metab. Dispos., 41: 1488-1493 (2013).
  • 5) Mirghani, R. A., Ericsson, O., Tybring, G., Gustafsson, L. L. and Bertilsson, L.: Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man. Eur. J. Clin. Pharmacol., 59: 23-28 (2003).
more...

Return to Previous Page